NUVATION BIO INC (NUVB)

US67080N1019 - Common Stock

2.89  +0.3 (+11.58%)

After market: 2.95 +0.06 (+2.08%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
2.16M0.000.000.000.00
Operating Expenses
133.75M99.82M112.33M93.32M43.55M
Research and Development
85.17M71.29M80.52M69.04M32.60M
Selling, General, and Administrative Expenses
48.58M28.53M31.82M24.28M10.95M
Operating Income
-134.45M-99.82M-112.33M-93.32M-43.55M
Interest Income/Expense
27.80M24.47M6.22M2.88M2.16M
Other Income/Expense
-563.00K-452.00K9.32M3.59M-270.00K
Non Recurring Items
N/AN/A-7.40MN/AN/A
Income Before Taxes
-532.28M-75.80M-104.20M-86.85M-41.66M
Income Tax
0.000.000.000.000.00
Net Income
-532.28M-75.80M-104.20M-86.85M-64.28M
EBITDA
-133.93M-99.60M-112.13M-93.14M-43.45M
 
Per Share Data
EPS Diluted Total Ops
-2.17-0.35-0.48-0.44-0.30
Non GAAP EPS
-0.43-0.34-0.48-0.44N/A
 
Statistics
Profit Margin
-24619.84%N/AN/AN/AN/A
Operating Profit Margin
-6218.59%N/AN/AN/AN/A

All data in USD

Charts